HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
451
Galapagos
GLPG
$2.1B
|
DC
Debjit Chattopadhyay
| $31.91 | $123 |
285%
upside
| Neutral | 5 years ago |
|
452
CorMedix
CRMD
$956M
|
RS
Raghuram Selvaraju
| $12.80 | $10 |
22%
downside
| Buy | 5 years ago |
|
453
CareDx
CDNA
$697M
|
RS
Raghuram Selvaraju
| $13.10 | $40 |
205%
upside
| Buy | 5 years ago |
|
454
Zymeworks
ZYME
$1.07B
|
DC
Debjit Chattopadhyay
| $14.08 | $54 |
284%
upside
| Buy | 5 years ago |
|
455
uniQure
QURE
$973M
|
DC
Debjit Chattopadhyay
| $17.73 | $64 |
261%
upside
| Buy | 5 years ago |
|
456
CytomX Therapeutics
CTMX
$346M
| $2.10 | $12 |
471%
upside
| Buy | 5 years ago |
|
|
457
scPharmaceuticals
SCPH
$300M
| $5.58 | $15 |
169%
upside
| Buy | 5 years ago |
|
|
458
Nektar Therapeutics
NKTR
$684M
|
CD
Corey Davis
| $35.98 | $390 |
984%
upside
| Neutral | 5 years ago |
|
459
Verastem
VSTM
$650M
|
SR
Swayampakula Ramakanth
| $10.56 | $33 |
213%
upside
| Buy | 5 years ago |
|
460
Alphatec Holdings
ATEC
$2.45B
|
SR
Swayampakula Ramakanth
| $16.55 | $9.50 |
43%
downside
| Buy | 5 years ago |
|
461
Pacira BioSciences
PCRX
$1.2B
| $26.73 | $63 |
136%
upside
| Buy | 5 years ago |
|
|
462
Patterson-UTI
PTEN
$2.25B
| $5.83 | $2 |
66%
downside
| Buy | 5 years ago |
|
|
463
Kodiak Sciences
KOD
$452M
|
MY
Michael Yee
| $8.55 | $100 |
1,070%
upside
| Buy | 5 years ago |
|